|
| Press Releases |
|
 |
|
| Tuesday, December 11, 2012 |
|
|
INC Research Appoints New Chief Information Officer to Lead Data Intelligence Initiatives |
| INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the appointment of Sal Chiovari as its new Chief Information Officer (CIO). more info >> |
|
| Friday, December 7, 2012 |
|
|
INC Research Strengthens Leadership for Strategic Advisory Services Unit |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the appointment of Robert Ryan, PhD, as Vice President, Regulatory Strategy, Consulting and Submissions. more info >> |
|
| Wednesday, December 5, 2012 |
|
|
INC Research Expands Global Consulting Capabilities Through New Strategic Advisory Services Unit |
| INC Research, LLC today launched INC Research Strategic Advisory Services, a new global business unit dedicated to providing biopharmaceutical customers with world-class consulting capabilities in the areas of drug development and commercialization, regulatory consulting and submissions, and quality assurance. more info >> |
|
| Monday, November 5, 2012 |
|
|
INC Research Discusses Benefits of Involving CROs Early in Planning at Partnerships in Clinical Trials 2012 |
| INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, will discuss the importance of involving CROs early in the planning process at the Partnerships in Clinical Trials conference, November 6-9, 2012 at the CCH Congress Center in Hamburg, Germany. more info >> |
|
| Wednesday, September 26, 2012 |
|
|
INC Research, LLC Third Quarter 2012 Results of Operations Release Date and Conference Call |
| INC Research, LLC (the "Company"), a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, will conduct a conference call to discuss its third quarter 2012 financial results at 11:00 a.m. ET on Tuesday, November 13, 2012. more info >> |
|
| Thursday, September 13, 2012 |
|
|
INC Research Expands South Korean Presence with New Office |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the opening of a facility in South Korea to manage the growing demand for world-class clinical development programs. more info >> |
|
| Thursday, September 6, 2012 |
|
|
INC Research's Susan Akers-Smith Promoted to Vice President, Early Phase Oncology Development |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the promotion of Susan Akers-Smith to Vice President, Early Phase Oncology Development. more info >> |
|
| Friday, August 24, 2012 |
|
|
INC Research Enhances Corporate Training Programs as the Only Global CRO Authorized Provider of IACET Continuing Education Units |
| INC Research, LLC today announced it has been accredited as an Authorized Provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs to ultimately enhance delivery of clinical development solutions of the highest quality for customers. more info >> |
|
| Friday, August 17, 2012 |
|
|
INC Research Announces CEO Succession Plan, Promotes Jamie Macdonald to CEO |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced that as part of a planned succession Chief Operating Officer (COO) Jamie Macdonald will become the Company's next President and Chief Executive Officer (CEO). more info >> |
|
| Tuesday, August 14, 2012 |
|
|
INC Research Launches "Perspectives" Webinar Series Providing Insights from Key Industry Thought Leaders on the Latest Thinking in Clinical Research |
| INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the launch of its "Perspectives" webinar series designed to bring together key industry experts and thought leaders to share the latest insights and best practices on the many facets of clinical research. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
True IDC Pushes "Security Economy", Breaking Ground on Mega Data Center in EEC with 77-Billion-Baht BOI Investment, Cementing Thailand's No. 1 Position
Apr 1, 2026 18:50 HKT/SGT
|
|
|
China Risun (01907.HK) Reports Strong 37.7% Net Profit Surge in 2025 Amid Industry Challenges
Apr 1, 2026 18:07 HKT/SGT
|
|
|
中國旭陽集團（01907.HK）積極面對行業變化 2025年淨利逆勢增長37.7%
Apr 1, 2026 17:50 HKT/SGT
|
|
|
中国旭阳集团（01907.HK）积极面对行业变化 2025年净利逆势增长37.7%
Apr 1, 2026 17:42 HKT/SGT
|
|
|
CTF Life Collaborates with the HKMC to Refer the Policy Reverse Mortgage Programme and the Reverse Mortgage Programme
Apr 1, 2026 16:20 HKT/SGT
|
|
|
周大福人壽與香港按揭證券有限公司合作
Apr 1, 2026 16:02 HKT/SGT
|
|
|
Yuanda China's 2025 Operating Revenue Surged 27% to RMB 2.8 Billion, with a Net Profit of RMB 0.35 Billion, turning losses into gains
Apr 1, 2026 15:00 HKT/SGT
|
|
|
遠大中國2025年營收大增27%至28億元 淨利潤3.5億元扭虧為盈
Apr 1, 2026 13:10 HKT/SGT
|
|
|
远大中国2025年营收大增27%至28亿元 净利润3.5亿元扭亏为盈
Apr 1, 2026 13:04 HKT/SGT
|
|
|
芯智控股2025年淨利潤大增60.8%至1.61億港元 AI戰略驅動業績創新高
Apr 1, 2026 12:56 HKT/SGT
|
|
|
芯智控股2025年净利润大增60.8%至1.61亿港元 AI战略驱动业绩创新高
Apr 1, 2026 12:46 HKT/SGT
|
|
|
純利躍升超26倍！品創控股（8066.HK）2025年AI + 私域雙輪開啟增長新週期
Apr 1, 2026 12:37 HKT/SGT
|
|
|
MHI President Eisaku Ito Offers Words of Encouragement to New Employees at the Company's 2026 Welcoming Ceremony
Apr 1, 2026 13:35 JST
|
|
|
纯利跃升超26倍！品创控股（8066.HK）2025年AI + 私域双轮开启增长新周期
Apr 1, 2026 12:28 HKT/SGT
|
|
|
MHI Completes the Transfer Procedures for its Domestic Onshore Wind Power Business
Apr 1, 2026 13:26 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
